According to Aurobindo Pharma 's latest financial reports the company's current earnings are HK$3.52 Billion. In 2023 the company made an earning of HK$3.87 Billion, an increase over its 2022 earnings that were of HK$2.49 Billion. The earnings displayed on this page is the company's Pretax Income.